Genetics in psychiatry - Up-to-date review 2011

Neuroendocrinology Letters

Volumn 32, Issue 4, 2011, Pages 389-399

  Ptacek, Radek ^a   Kuzelova, Hana ^a   Stefano, George B ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Genes; Genetic variants; Polymorphism; Psychiatric genetics

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE BETA MONOOXYGENASE; DOPAMINE TRANSPORTER; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEU DIFFERENTIATION FACTOR; NORADRENALIN TRANSPORTER; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE; TRYPTOPHAN HYDROXYLASE 1; TRYPTOPHAN HYDROXYLASE 2; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER 1; VESICULAR MONOAMINE TRANSPORTER 2;

COPY NUMBER VARIATION; ENVIRONMENTAL FACTOR; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENETICS; HUMAN; MENTAL DISEASE; PSYCHIATRIC GENETICS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 80053592261     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (196)

1. Aguiar-Pulido V, Seoane JA, Rabuñal JR, Dorado J, Pazos A, Munteanu CR (2010) Machine learning techniques for single nucleotide polymorphism-disease classification models in schizophrenia. Molecules. 12: 15(7): 4875-89.
2. Albert PR, Lemonde S (2004) 5-HT1A receptors, gene repression, and depression: guilt by association. Neuroscientist. 10(6): 575-93. (Pubitemid 39546399)
3. Arai M (2011) Increased plasma arginine vasopressin levels in dopamine agonist-treated Parkinson's disease patiens. Neuroendocrinol Lett. 32(1): 39-43.
4. Atmanene C, Laux A, Glattard E, Muller A, Schoentgen F, Metz-Boutigue MH, Aunis D, van Dorsselaer A, Stefano G, Sanglier-Cianferani S, Goumon (2009) Characterization of human and bovine phosphatidylethanolamine-binding protein (PEBP/RKIP) interactions with morphine and morphine-glucuronides determined by noncovalent mass spectrometry. Med Sci Monit. 15(7): BR178-187.
5. Bai YM, Chen TT, Liou YJ, Hong CJ, Tsai SJ (2011) Association between HTR2C polymorphisms and metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics. Schizophr Res. 125(2-3): 179-86.
6. Banaschewski T, Becker K, Scherag S, Franke B, Coghill D (2010) Molecular genetics of attention-deficit/hyperactivity disorder: an overview. Eur Child Adolesc Psychiatry. 19(3): 237-57.
7. Batel P., Houchi H., Daoust M., Ramoz N., Naassila M., Gorwood P (2008) A haplotype of the DRD1 gene is associated with alcohol dependence. Alcohol Clin Exp Res. 32: 567-72. (Pubitemid 351430427)
8. Becker K, Blomeyer D, El-Faddagh M, Esser G, Schmidt MH, Banaschewski T, Laucht M (2010) From Regulatory Problems in Infancy to Attention-Deficit/ Hyperactivity Disorder in Childhood: A Moderating Role for the Dopamine D4 Receptor Gene? J Pediatr. [Epub ahead of print]
9. Bellgrove MA, Hawi Z, Kirley A, Fitzgerald M, Gill M, Robertson IH (2005) Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder. Neuropsychopharmacology. 30(12): 2290-7. (Pubitemid 41643982)
10. Benedetti F, Radaelli D, Poletti S, Locatelli C, Dallaspezia S, Lorenzi C, Pirovano A, Colombo C, Smeraldi E (2011) Association of the C(-1019)G 5-HT1A promoter polymorphism with exposure to stressors preceding hospitalization for bipolar depression. J Affect Disord. [Epub ahead of print]
11. Blom RM, Samuels JF, Riddle MA, Joseph Bienvenu O, Grados MA, Reti IM, Eaton WW, Liang KY, Nestadt G (2011) Association between a serotonin transporter promoter polymorphism (5HTTLPR) and personality disorder traits in a community sample. J Psychiatr Res. [Epub ahead of print]
12. Bobb AJ, Addington AM, Sidransky E, Gornick MC, Lerch JP, Greenstein DK et al (2005) Support for association between ADHD and two candidate genes: NET1 and DRD1. Am J Med Genet B Neuropsychiatr Genet. 5: 67-72. (Pubitemid 40411112)
13. Boso M, Comelli M, Emanuele E, Podavini F, Marini M, Mancini L, Ucelli di Nemi S, Barale F, Politi P (2010) Seasonal fluctuations in problem behaviors among young adults with autism and intellectual disability. Med Sci Monit. 16(5): CR213-6.
14. Breitling LP, Twardella D, Hoffmann MM, Witt SH, Treutlein J, Brenner H (2010) Prospective association of dopamine-related polymorphisms with smoking cessation in general care. Pharmacogenomics. 11(4): 527-36.
15. Casares FM, Mantione KJ, Kream RM, et al (2009) Neurotransmitter Gene Microarray Analysis in Human White Blood Cells and Human Stem Cells Following Morphine Exposure. Act Nerv Super Rediviva 51: 127-132.
16. Charoenphandhu J, Teerapornpuntakit J, Nuntapornsak A, Krishnamra N, Charoenphandhu N (2011) Anxiety-like behaviors and expression of SERT and TPH in the dorsal raphé of estrogen- and fluoxetine-treated ovariectomized rats. Pharmacol Biochem Behav. 5. 98(4): 503-510. [Epub ahead of print].
17. Chee IS, Lee SW, Kim JL, Wang SK, Shin YO, Shin SC, Lee YH, Hwang HM, Lim M (2001) 5-HT2A receptor gene promoter polymorphism -1438A/G and bipolar disorder. Psychiatr Genet. 11(3): 111-4. (Pubitemid 32980609)
18. Cheon KA, Ryu YH, Kim JW, Cho DY (2005) The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate. Eur Neuropsychopharmacol. 15(1): 95-101.
19. Chien CC, Lin CH, Chang YY, Lung FW (2010) Association of VNTR polymorphisms in the MAOA promoter and DRD4 exon 3 with heroin dependence in male Chinese addicts. World J Biol Psychiatry. 11 (2 Pt 2): 409-16.
20. Cho SC, Kim JW, Kim BN, Hwang JW, Park M, Kim SA, Cho DY, Yoo HJ, Chung US, Son JW, Park TW (2008) No evidence of an association between norepinephrine transporter gene polymorphisms and attention deficit hyperactivity disorder: a family-based and case-control association study in a Korean sample. Neuropsychobiology. 57(3): 131-8. Epub 2008 Jun 13.
21. Coccini T, Crevani A, Rossi G, Assandri F, Balottin U, Nardo RD, Manzo L (2009) Reduced platelet monoamine oxidase type B activity and lymphocyte muscarinic receptor binding in unmedicated children with attention deficit hyperactivity disorder. Biomarkers. 14(7): 513-22.
22. Coghill D, Banaschewski T (2009) The genetics of attention-deficit/ hyperactivity disorder. Expert Rev Neurother. 9(10): 1547-65.
23. Comings DE, Gade R, Wu S, Chiu C, Dietz G, Muhleman D et al (1997) Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors. Mol Psychiatry. 2:44-56. (Pubitemid 27163110)
24. Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Chen C et al (2001) The additive effect of neurotransmitter genes in pathological gambling. Clin Genet. 60: 107-16. (Pubitemid 32791664)
25. Contini V, Victor MM, Marques FZ, Bertuzzi GP, Salgado CA, Silva KL, Sousa NO, Grevet EH, Belmonte-de-Abreu P, Bau CH (2010) Response to methylphenidate is not influenced by DAT1 polymorphisms in a sample of Brazilian adult patients with ADHD. J Neural Transm. 117(2): 269-76.
26. Costas J, Sanjuán J, Ramos-Ríos R, Paz E, Agra S, Ivorra JL, Páramo M, Brenlla J, Arrojo M (2010) Heterozygosity at catechol-O-methyltransferase Val158Met and schizophrenia: New data and meta-analysis. J Psychiatr Res. [Epub ahead of print]
27. Craig IW, Halon KE (2009) Genetics of human aggressive behavior Hum Genet. 126: 101-113.
28. Croonenberghs J, Grieken S, Wauters A, West D, Brouw L, Maes M (2010) Serum testosterone concentration in male autistic youngsters. Neuroendocrinol Lett. 31(4): 483-488.
29. Da Silva Lobo DS, Vallada HP, Knight J, Martins SS, Tavares H, Gentil V et al (2007) Dopamine genes and pathological gambling in discordant sib-pairs. J Gambl Stud. 23: 421-33.
30. Davies GE, Soundy TJ (2009) The genetics of smoking and nicotine addiction. S D Med. Spec No: 43-9.
31. Davis C, Patte K, Levitan RD, Carter J, Kaplan AS, Zai C, Reid C, Curtis C, Kennedy JL (2009) A psycho-genetic study of associations between the symptoms of binge eating disorder and those of attention deficit (hyperactivity) disorder. J Psychiatr Res. 43(7): 687-96.
32. De Krom M, Staal WG, Ophoff RA, Hendriks J, Buitelaar J, Franke B, De Jonge MV, Bolton P, Collier D, Curran S, van Engeland H, van Ree JM (2009) A common variant in DRD3 receptor is associated with autism spectrum disorder. Biol Psychiatry. 65(7): 625-30.
33. Dell'osso B, Palazzo MC, Oldani L, Altamura AC (2010) The Noradrenergic Action in Antidepressant Treatments: Pharmacological and Clinical Aspects. CNS Neurosci Ther. [Epub ahead of print]
34. Dick DM, Wang JC, Plunkett J, Aliev F, Hinrichs A, Bertelsen S et al (2007) Family-based association analyses of alcohol dependence phenotypes across DRD2 and neighboring gene ANKK1. Alcohol Clin Exp Res. 31: 1645-53. (Pubitemid 47390031)
35. Dmitrieva J, Chen C, Greenberger E, Ogunseitan O, Ding YC (2010) Gender-specific expression of the DRD4 gene on adolescent delinquency, anger and thrill seeking. Soc Cogn Affect Neurosci. [Epub ahead of print].
36. Dogan I, Onen H, Yurdakul A, Konac E, Ozturk E, Varol E, Ekmekci A (2009) Polymorphisms in the vitamin D receptor gene and risk of lung cancer. Med Sci Monit. 15(8): BR232-242.
37. Dominguez E, Loza MI, Padin F, Gesteira A, Paz E, Paramo M, Brenlla J, Pumar E, Iglesias F, Cibeira A et al. (2007) Extensive linkage disequilibrium mapping at HTR2A and DRD3 for schizophrenia susceptibility genes in the Galician population. Schizophr Res. 90: 123-129. (Pubitemid 46201673)
38. Du Y, Yang M, Yeh HW, Wan YJ (2010) The association of exon 3 VNTR polymorphism of the dopamine receptor D4 (DRD4) gene with alcoholism in Mexican Americans. Psychiatry Res. 177(3): 358-360.
39. Efimov RV, Mavlyudova AS, Golimbet VE (2009) [Association between the tryptophan hydroxylase (TPH) gene polymorphic markers and endogenous psychoses] Genetika. 45(12): 1668-73 (In Russian).
40. Emanuele E, Boso M, Cassola F, Broglia D, Bonoldi I, Mancini L, Marini M, Politi P. (2010b). Increased dopamine DRD4 receptor mRNA expression in lymphocytes of musicians and autistic individuals: bridging the music-autism connection. Neuroendocrinol Lett. 31(1): 122-125.
41. Emanuele E, Colombo R, Martinelli V, Brondino N, Marini M, Boso M, Barale F, Politi P. (2010a). Elevated urine levels of bufotenine in patients with autistic spectrum disorders and schizophrenia. Neuroendocrinol Lett. 31(1): 117-121.
42. Esch T, Stefano GB (2010) The neurobiology of stress management. Neuroendocrinol Lett. 31(1): 19-39.
43. Esch T, Stefano GB (2011) The neurobiological link between compassion and love. Med Sci Monit. 17: RA65-RA75.
44. Fatemi SH, Reutiman TJ, Folsom TD, Rooney RJ, Patel DH, Thuras P (2010) mRNA and protein levels for GABAAalpha4, alphas, beta1 and GABABR1 receptors are altered in brains from subjects with autism. J Autism Dev Disord. 40(6): 743-50.
45. Felicio AC, Moriyama TS, Godeiro-Junior C, Shih MC, Hoexter MQ, Borges V, Silva SM, Amaro-Junior E, Andrade LA, Ferraz HB, Bressan RA (2010) Higher dopamine transporter density in Parkinson's disease patients with depression. Psychopharmacology (Berl). [Epub ahead of print].
46. Fernàndez-Castillo N, Ribasés M, Roncero C, Casas M, Gonzalvo B, Cormand B (2010) Association study between the DAT1, DBH and DRD2 genes and cocaine dependence in a Spanish sample. Psychiatr Genet. [Epub ahead of print].
47. Fisar Z, Hroudová J, Raboch J (2010) Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers. Neuroendocrinol Lett. 31(5): 645-56.
48. Formisano R, Cicinelli P, Buzzi MG, Brunelli S, Zafonte R, Vinicola V, Gabrielli A, Sabatini U (2009) Blink reflex changes in parkinsonism following severe traumatic brain injury correlates with diffuse axonal Indry. Med Sci Monit. 15(3): CR101-106.
49. Fricchione G, Zhu W, Cadet P, et al (2008) Identification of endogenous morphine and a mu3-like opiate alkaloid receptor in human brain tissue taken from a patient with intractable complex partial epilepsy. Med Sci Mon. 14: CS45-CS49. (Pubitemid 351929695)
50. Galecki P, Szemraj J, Florkowski A, Talarowska M, Bienkiewicz M, Galecka E, Lewinski (2010) Single nucleotide polymorphism of the KIBRA gene in recurrent depressive disorders. Neuroendocrinol Lett. 31(1): 97-102.
51. Galinska B, Szulc A, Tarasow E, Kubas B, Dzienis W, Czernikiewicz A, Walecki J (2009) Duration of untreated psychosis and proton magnetic resonance spectroscopy (1H-MRS) findings in first-episode schizophrenia. Med Sci Monit. 15(2): CR82-CR88.
52. Gatewood JD, Wills A, Shetty S, Xu J, Arnold AP, Burgoyne PS, Rissman EF (2006) Sex chromosome complement and gonadal sex influence aggressive and parental behaviors in mice. J Neurosci. 26: 2335-2342. (Pubitemid 44699043)
53. Gizer IR, Ficks C, Waldman ID (2009) Candidate gene studies of ADHD: a meta-analytic review. Hum Genet. 126(1): 51-90.
54. Gleason G, Liu B, Bruening S, Zupan B, Auerbach A, Mark W, Oh JE, Gal-Toth J, Lee F, Toth M (2010) The serotonin1A receptor gene as a genetic and prenatal maternal environmental factor in anxiety. Proc Natl Acad Sci USA. 107(16): 7592-7.
55. Golimbet VE, Alfimova MV, Gritsenko IK, Lezheiko TV, Ebstein R (2008) Association of dopamine receptor D5 gene polymorphism with peculiarities of voluntary attention in schizophrenic patients and their relatives. Bull Exp Biol Med. 145(1): 65-7.
56. Guo G, Cai T, Guo R, Wang H, Harris KM (2010) The dopamine transporter gene, a spectrum of most common risky behaviors, and the legal status of the behaviors. PLoS One. 5(2): e9352.
57. Guo G, Roettger ME, Shih JC (2007) Contributions of the DAT1 and DRD2 genes to serious and violent delinquency among adolescents and young adults. Hum Genet. 121(1): 125-36. (Pubitemid 46421149)
58. Hack LM, Kalsi G, Aliev F, Kuo PH, Prescott CA, Patterson DG, Walsh D, Dick DM, Riley BP, Kendler KS (2011) Limited associations of dopamine system genes with alcohol dependence and related traits in the Irish Affected Sib Pair Study of Alcohol Dependence (IASPSAD). Alcohol Clin Exp Res. 35(2): 376-85.
59. Hamidovic A, Dlugos A, Palmer AA, De Wit H (2010) Catechol-O- methyltransferase val158met genotype modulates sustained attention in both the drug-free state and in response to amphetamine. Psychiatr Genet. 20(3): 85-92.
60. Hernando R (2010) Cerebral atherosclerosis causes neurodegenerative diseases Med Sci Monit. 16(1): LE1-2.
61. Hess C, Reif A, Strobel A, Boreatti-Hummer A, Heine M, Lesch KP, Jacob CP (2009) A functional dopamine-beta-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with aVective disorders. J Neural Transm. 116: 121-130.
62. Hoenicka J, Garrido E, Ponce G, Rodríguez-Jiménez R, Martínez I, Rubio G, Jiménez-Arriero MA, Palomo T (2010) Sexually dimorphic interaction between the DRD1 and COMT genes in schizophrenia. Am J Med Genet B Neuropsychiatr Genet. [Epub ahead of print].
63. Hohmann S, Becker K, Fellinger J, Banaschewski T, Schmidt MH, Esser G, Laucht M (2009) Evidence for epistasis between the 5-HTTLPR and the dopamine D4 receptor polymorphisms in externalizing behavior among 15-year-olds. J Neural Transm. 116(12): 1621-9.
64. Hosák L, Libiger J, Cizek J, Beránek M, Cermáková E (2006) The COMT Val158Met polymorphism is associated with novelty seeking in Czech methamphetamine abusers: preliminary results. Neuroendocrinol Lett. 27(6): 799-802.
65. Hrdlicka M. (2008a). Structural neuroimaging in autism. Neuroendocrinol Lett. 29(3): 281-6.
66. Hrdlicka M. (2008b). EEG abnormalities, epilepsy and regression in autism: a review. Neuroendocrinol Lett. 29(4): 405-9.
67. Hruby R, Nosalova G, Hruba S (2010) Predictive significance of TCI-R for antidepressant treatment. Med Sci Monit. 16(8): CR383-8.
68. Huang W, Ma JZ, Payne TJ, Beuten J, Dupont RT, Li MD (2008) Significant association of DRD1 with nicotine dependence. Hum Genet. 123(2): 133-40.
69. Huang W, Payne TJ, Ma JZ, Beuten J, Dupont RT, Inohara N et al (2009) Significant association of ANKK1 and detection of a functional polymorphism with nicotine dependence in an African-American sample. Neuropsychopharmacology. 34: 319-30.
70. Husarova V, Ondrejka I, Tonhajzerova I (2010) Potential pathomechanisms of ADHD based on neurometabolite changes. Neuroendocrinol Lett. 31(4): 438-445.
71. Idova GV, Iur'ev DV, Kuznetsova SM. (2010) [Immune response under activation of pre- and postsynaptic serotonin 5-HT1A-receptors in mice with depressive-like behavior]. [Article in Russian] Ross Fiziol Zh Im I M Sechenova. 96(11): 1097-102.
72. Iritani S, Sekiguchi H, Habuchi C, Hikita T, Taya S, Kaibuchi K, Ozaki N (2010) Immunohistochemical study of vesicle monoamine transporter 2 in the hippocampal region of genetic animal model of schizophrenia. Synapse. 64(12): 948-53.
73. Ishiguro H, Onaivi ES, Horiuchi Y, Imai K, Komaki G, Ishikawa T, Suzuki M, Watanabe Y, Ando T, Higuchi S, Arinami T (2010) Functional polymorphism in the GPR55 gene is associated with Anorexia Nervosa. Synapse. [Epub ahead of print].
74. Itoi K, Sugimoto N (2010) The brainstem noradrenergic systems in stress, anxiety and depression. J Neuroendocrinol. 22(5): 355-61.
75. Jovanovic V, Guan HC, van Tol HH (1999) Comparative pharmacological and functional analysis of the human dopamine D4.2 and D4.10 receptor variants. Pharmacogenetics. 9: 561-8.
76. Kaluzna-Czaplinska J, Michalska M, Rynkowski J (2010a) Determination of tryptophan in urine of autistic and healthy children by gas chromatography/mass spectrometry. Med Sci Monit. 16(10): CR488-92.
77. Kaluzna-Czaplińska J, Socha E, Rynkowski J (2010b) Determination of homovanillic acid and vanillylmandelic acid in urine of autistic children by gas chromatography/mass spectrometry. Med Sci Monit. 16(9): CR445-50.
78. Kang JI, Namkoong K, Kim SJ (2008) Association of DRD4 and COMT polymorphisms with anger and forgiveness traits in healthy volunteers. Neurosci Lett. 430(3): 252-7.
79. Kasiakogia-Worlley K, McQuillin A, Lydall GJ, Patel S, Kottalgi G, Gunwardena P, Cherian R, Rao H, Hillman A, Gobikrishnan N, Douglas E, Qureshi SY, Jauhar S, Ball D, O'Kane A, Owens L, Dedman A, Sharp SI, Kandaswamy R, Guerrini I, Thomson AD, Smith I, Dar K, Morgan MY, Gurling HM (2011) Lack of allelic association between markers at the DRD2 and ANKK1 gene loci with the alcohol-dependence syndrome and criminal activity. Psychiatr Genet. [Epub ahead of print].
80. Kebir O, Joober R (2011) Neuropsychological endophenotypes in attention-deficit/hyperactivity disorder: a review of genetic association studies. Eur Arch Psychiatry Clin Neurosci. [Epub ahead of print].
81. Kebir O, Tabbane K, Sengupta S, Joober R (2009) Candidate genes and neuropsychological phenotypes in children with ADHD: review of association studies. J Psychiatry Neurosci. 34(2): 88-101.
82. Kenna GA (2010) Medications Acting on the Serotonergic System for the Treatment of Alcohol Dependent Patients. Curr Pharm Des. [Epub ahead of print].
83. Kereszturi E, Tarnok Z, Bognar E, Lakatos K, Farkas L, Gadoros J, Sasvari-Szekely M, Nemoda Z (2008) Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children. Am J Med Genet B Neuropsychiatr Genet. 147B(8): 1431-5.
84. Kim H, Lim SW, Kim S, Kim JW, Chang YH, Carroll BJ, Kim DK (2006) Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression. JAMA. 296(13): 1609-18. (Pubitemid 44511608)
85. Kim SK, Lee SI, Shin CJ, Son JW, Ju G (2010) The genetic factors affecting drinking behaviors of korean young adults with variant aldehyde dehydrogenase 2 genotype. Psychiatry Investig. 7(4): 270-7.
86. Kim YK, Yoon HK (2011) Effect of Serotonin-Related Gene Polymorphisms on Pathogenesis and Treatment Response in Korean Schizophrenic Patients. Behav Genet. [Epub ahead of print].
87. Kishi T, Tsunoka T, Ikeda M, Kitajima T, Kawashima K, Okochi T, Okumura T, Yamanouchi Y, Kinoshita Y, Ujike H, Inada T, Yamada M, Uchimura N, Sora I, Iyo M, Ozaki N, Iwata N (2010) Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients. Neuropharmacology. 58(2): 452-6.
88. Kishi T, Yoshimura R, Kitajima T, Okochi T, Okumura T, Tsunoka T, Yamanouchi Y, Kinoshita Y, Kawashima K, Naitoh H, Nakamura J, Ozaki N, Iwata N (2010) HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort. Neuromolecular Med. 12(3): 237-42.
89. Kollins SH, Anastopoulos AD, Lachiewicz AM, FitzGerald D, Morrissey-Kane E, Garrett ME, Keatts SL, Ashley-Koch AE (2008) SNPs in dopamine D2 receptor gene (DRD2) and norepinephrine transporter gene (NET) are associated with continuous performance task (CPT) phenotypes in ADHD children and their families. Am J Med Genet B Neuropsychiatr Genet. 147B(8): 1580-8.
90. Kong F, Peng Z, Jiang T, Hong X (2011) [An association study of COMT gene polymorphisms with schizophrenia.] [Article in Chinese] Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 28(2): 208-211.
91. Kopecková M, Paclt I, Petrásek J, Pacltová D, Malíková M, Zagatová V (2008) Some ADHD polymorphisms (in genes DAT1, DRD2, DRD3, DBH, 5-HTT) in case-control study of 100 subjects 6-10 age. Neuroendocrinol Lett. 29(2): 246-51.
92. Kovács-Nagy R, Hu J, Rónai Z, Sasvári-Székely M (2009) SNAP-25: a novel candidate gene in psychiatric genetics. Neuropsychopharmacol Hung. 11(2): 89-94.
93. Kranzler HR, Edenberg HJ (2010) Pharmacogenetics of Alcohol and Alcohol Dependence Treatment. Curr Pharm Des. [Epub ahead of print].
94. Kream RM, Mantione KJ, Sheehan M, et al (2009) Morphine's chemical messenger status in animals. Activitas Nervosa Superior Rediviva. 51: 153-161.
95. Kream RM, Stefano GB, Ptacek R (2010) Psychiatric Implications of Endogenous Morphine: Up-To-Date Review. Folia Biologica: Journal of Cellular and Molecular Biology. 56: 231-241.
96. Kream RM, Stefano GB. (2006a). De novo biosynthesis of morphine in animal cells: An evidence-based model. Med Sci Monit. 12: RA207-RA219. (Pubitemid 44556096)
97. Kream RM, Stefano GB. (2006b). Morphine synthesis in animals (Editorial). Med Sci Monit. 12: ED1-ED2. (Pubitemid 44556092)
98. Kream RM, Stefano GB (2009) Endogenous morphine and nitric oxide coupled regulation of mitochondrial processes. Med Sci Monit. 15: RA263-RA268.
99. Kuzelova H, Ptacek R, Macek M (2010) The serotonin transporter gene (5-HTT) variant and psychiatric disorders: review of current literature. Neuroendocrinol Lett. 31(1): 4-10.
100. Langley K, Fowler TA, Grady DL, Moyzis RK, Holmans PA, van den Bree MB, Owen MJ, O'Donovan MC, Thapar A (2009) Molecular genetic contribution to the developmental course of attention-deficit hyperactivity disorder. Eur Child Adolesc Psychiatry. 18(1): 26-32.
101. Lanzenberger RR, Mitterhauser M, Spindelegger C et al (2007) Reduced serotonin-1 A receptor binding in social anxiety disorder. Biol Psychiatry. 61: 1081-1089. (Pubitemid 46551966)
102. Latalova K, Prasko J, Diveky T, Grambal A, Kamaradova D, Velartova H, Salinger J, Opavsky J (2010) Autonomic nervous system in euthymic patients with bipolar affective disorder. Neuroendocrinol Lett. 31(6): 829-36.
103. Le Foll B, Gallo A, Le Strat Y, Lu L, Gorwood P (2009) Genetics of dopamine receptors and drug addiction: a comprehensive review. Behav Pharmacol. 20(1): 1-17.
104. Lee SY, Chen SL, Chen SH, Huang SY, Tzeng NS, Chang YH, Wang CL, Lee IH, Yeh TL, Yang YK, Lu RB (2010) The COMT and DRD3 genes interacted in bipolar I but not bipolar Il disorder. World J Biol Psychiatry. [Epub ahead of print].
105. Leggio GM, Micale V, Le Foll B, Mazzola C, Nobrega JN, Drago F (2011) Dopamine D(3) receptor knock-out mice exhibit increased behavioral sensitivity to the anxiolytic drug diazepam. Eur Neuropsychopharmacol. 21(4): 325-32.
106. Lencz T, Robinson DG, Xu K, Ekholm J, Sevy S, Gunduz-Bruce H, Woerner MG, Kane JM, Goldman D, Malhotra AK (2006) DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patients. Am J Psychiatry. 163(3): 529-31. (Pubitemid 44469398)
107. Levitan RD, Kaplan AS, Davis C, Lam RW, Kennedy JL (2010) A Season-of-Birth/DRD4 Interaction Predicts Maximal Body Mass Index in Women with Bulimia Nervosa. Neuropsychopharmacology. [Epub ahead of print].
108. Lim SW, Ha J, Shin DW, Woo HY, Kim KH (2010) Associations between the serotonin-1A receptor C(-1019)G polymorphism and disordered eating symptoms in female adolescents. J Neural Transm. [Epub ahead of print].
109. Liu H, Wang HT, Han F, Shi YX (2011) Activity of 5-HT1A receptor is involved in neuronal apoptosis of the amygdala in a rat model of post-traumatic stress disorder. Mol Med Report. 4(2): 291-5.
110. Lohoff FW, Bloch PJ, Hodge R, Nall AH, Ferraro TN, Kampman KM, Dackis CA, O'Brien CP, Pettinati HM, Oslin DW (2010) Association analysis between polymorphisms in the dopamine D2 receptor (DRD2) and dopamine transporter (DAT1) genes with cocaine dependence. Neurosci Lett. [Epub ahead of print].
111. Lohoff FW (2010) Genetic variants in the vesicular monoamine transporter 1 (VMAT1/SLC18A1) and neuropsychiatric disorders. Methods Mol Biol. 637:165-80.
112. Mantione K, Angert R, Cadet P, Kream R, Stefano G. (2010d). Identification of a micro opiate receptor signaling mechanism in human placenta. Med Sci Monit. 16(11): BR347-352.
113. Mantione KJ, Cadet P, Zhu W et al (2008) Endogenous morphine signaling via nitric oxide regulates the expression of CYP2D6 and COMT: autocrine/paracrine feedback inhibition. Addict Biol. 13: 118-123. (Pubitemid 351202129)
114. Mantione KJ, Goumon Y, Esch T et al (2005) Morphine 6b glucuronide: Fortuitous morphine metabolite or preferred peripheral regulatory opiate? Med Sci Monit. 11: MS43-MS46. (Pubitemid 40790949)
115. Mantione KJ, Kream RM, Stefano GB (2010a). Catechol-O-methyltransferase: Potential Relationship to Idiopathic Hypertension. Archives of Medical Science. 6: 291-295.
116. Mantione KJ, Kream RM, Stefano GB (2010b). Variations in critical morphine biosynthesis genes and their potential to influence human health. Neuroendocrinol Lett. 31: 11-18.
117. Mantione KJ, Zhu W, Kream RM ef al. (2010c). Regulation of the Transcription of the Catechol-O-Methyltransferase Gene by Morphine and Epinephrine. Act Nerv Super Rediviva. 52: 51-56.
118. Martirosian G, Ekiel A, Aptekorz M, Kazek B, Marszal E, Jankowska-Steifer E, Moskalewski S (2009) Intestinal anaerobic bacteria and autistic mind: is there some relations? Comment to: the autistic mind: a case study - Med Sci Monit. 15(1): CS5-13. Med Sci Monit. 15(3): LE2-3.
119. Markiewicz K, MacQueen (2009) The autistic mind: A case study. Med Sci Monit. 15(1): CS5-13.
120. McQueen MB, Devlin B, Faraone SV, Nimgaonkar VL, Sklar P, Smoller JW, Abou Jamra R, Albus M, Bacanu SA, Baron M, Barrett TB, Berrettini W, Blacker D, Byerley W, Cichon S, Coryell W, Craddock N, Daly MJ, Depaulo JR, Edenberg HJ, Foroud T, Gill M, Gilliam TC, Hamshere M, Jones I, Jones L, Juo SH, Kelsoe JR, Lambert D, Lange C, Lerer B, Liu J, Maier W, Mackinnon JD, Mclnnis MG, McMahon FJ, Murphy DL, Nothen MM, Nurnberger JI, Pato CN, Pato MT, Potash JB, Propping P, Pulver AE, Rice JP, Rietschel M, Scheftner W, Schumacher J, Segurado R, van Steen K, Xie W, Zandi PP, Laird NM. (2005a). Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am J Hum Genet. 77: 582-595. (Pubitemid 41361605)
121. Melkersson K (2011) The insulin receptor substrate-4 (IRS-4) gene and schizophrenia: no evidence for a main genetic factor, however one report of a single schizophrenia patient with a mutation. Neuroendocrinol Lett. 32(1). [Epub ahead of print]
122. Miczek KA, De Almeida RM, Kravitz EA, Rissman EF, De Boer SF, Raine A (2007) Neurobiology of escalated aggression and violence. J Neurosci. 27(44): 11803-6. (Pubitemid 350072089)
123. Min W, Li T, Ma X, Li Z, Yu T, Gao D, Zhang B, Yun Y, Sun X (2009) Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response. Psychopharmacology (Berl). 205(3): 409-17.
124. Misterska E, Glowacki M, Harasymczuk J (2010) Personality characteristics of females with adolescent idiopathic scoliosis after brace or surgical treatment compared to healthy controls. Med Sci Monit. 16(12): CR606-15.
125. Mustapić M, Pivac N, Kozarić-Kovacić D, Dezeljin M, Cubells JF, Mück-Seler D (2007) Dopamine beta-hydroxylase (DBH) activity and -1021C/T polymorphism of DBH gene in combat-related post-traumatic stress disorder. Am J Med Genet B Neuropsychiatr Genet. 144B(8): 1087-9.
126. Nedic G, Pivac N, Hercigonja DK, Jovancevic M, Curkovic KD, Muck-Seler D (2010) Platelet monoamine oxidase activity in children with attention-deficit/ hyperactivity disorder. Psychiatry Res. 175(3): 252-5.
127. Nemoda Z, Lyons-Ruth K, Szekely A, Bertha E, Faludi G, Sasvari-Szekely M. (2010) Association between dopaminergic polymorphisms and borderline personality traits among at-risk young adults and psychiatric inpatients. Behav Brain Funct. 6: 4.
128. Norrholm SD, Ressler KJ (2009) Genetics of anxienty and trauma-related disorders. Neuroscience. 164: 272-287.
129. Novak G, Leblanc M, Zai C, Shaikh S, Renou J, Deluca V, Bulgin N, Kennedy JL, Le Foll B (2010) Association of polymorphisms in the BDNF, DRD1 and DRD3 genes with tobacco smoking in schizophrenia. Ann Hum Genet. [Epub ahead of print].
130. Novak G, LeBlanc M, Zai C, Shaikh S, Renou J, DeLuca V, Bulgin N, Kennedy JL, Le Foll B (2010) Association of polymorphisms in the BDNF, DRD1 and DRD3 genes with tobacco smoking in schizophrenia. Ann Hum Genet. 74(4): 291-8.
131. Oades RD, Lasky-Su J, Christiansen H, Faraone SV, Sonuga-Barke EJ, Banaschewski T, Chen W, Anney RJ, Buitelaar JK, Ebstein RP, Franke B, Gill M, Miranda A, Roeyers H, Rothenberger A, Sergeant JA, Steinhausen HC, Taylor EA, Thompson M, Asherson P (2008) The influence of serotonin- and other genes on impulsive behavioral aggression and cognitive impulsivity in children with attention-deficit/hyperactivity disorder (ADHD): Findings from a family-based association test (FBAT) analysis. Behav Brain Funct. 4: 48.
132. Ohaeri JU, Awadalla AW, Gado OM (2010) Relationship between symptoms of major depressive and generalized anxiety disorders in an Arab population using diagnostic criteria-based instruments. Med Sci Monit. 16(12): PH103-15.
133. Paclt I, Drtilkova I, Kopeckova M, Theiner P, Serý O, Cermakova N (2010) The association between Taql A polymorphism of ANKK1 (DRD2) gene and ADHD in the Czech boys aged between 6 and 13 years. Neuroendocrinol Lett. 31(1): 20. [Epub ahead of print].
134. Paclt I, Koudelová J, Pacltova D, Kopeckova M (2009) Dopamine beta hydroxylase (DBH) plasma activity in childhood mental disorders. Neuroendocrinol Lett. 30(5): 604-9.
135. Pal P, Mihanović M, Molnar S, Xi H, Sun G, Guha S, Jeran N, Tomljenović A, Malnar A, Missoni S, Deka R, Rudan P (2009) Association of tagging single nucleotide polymorphisms on 8 candidate genes in dopaminergic pathway with schizophrenia in Croatian population. Croat Med J. 50(4): 361-9.
136. Pastucha P, Prasko J, Grambal A, Latalova K, Sigmundova Z, Sykorova T, Tichackova A. (2009b). Panic disorder and dissociation - comparison with healthy controls. Neuroendocrinol Lett. 30(6): 774-8.
137. Pastucha P, Prasko J, Grambal A, Latalova K, Sigmundova Z, Tichackova A. (2009a). Dissociative disorder and dissociation - comparison with healthy controls. Neuroendocrinol Lett. 30(6): 769-73.
138. Pawel K, Hauser J, Skibińska M, Szczepankiewicz A, Dmitrzak-Weglarz M, Gorzkowska K, Pawlak J, Czerski PM (2010) [Family based association study of DRD1, DRD2, DRD3, DRD4, DAT, COMT gene polymorphism in schizophrenia]. [Article in Polish] Psychiatr Pol. 44(3): 405-13.
139. Perez de Castro I, Ibanez A, Saiz-Ruiz J, Fernandez-Piqueras J (1999) Genetic contribution to pathological gambling: possible association between a functional DNA polymorphism at the serotonin transporter gene (5-HTT) and affected men. Pharmacogenetics. 9: 397-400. (Pubitemid 29376385)
140. Perez de Castro I, Ibanez A, Saiz-Ruiz J, Fernandez- Piqueras J (2002) Concurrent positive association between pathological gambling and functional DNA polymorphisms at the MAO-A and the 5-HT transporter genes. Mol Psychiatry. 7: 927-8. (Pubitemid 35333044)
141. Pietras T, Panek M, Kuprys-Lipinska I, Oszajca K, Wujcik R, Kuna P, Gorski P, Szemraj J (2010) Frequencies of Bcl 1, E22E, and N363S of h-GR/NR3C1 restriction fragment length polymorphisms of glucocorticoid receptor gene in Polish adult population. Med Sci Monit. 16(10): CR475-479.
142. Pietras T, Szemraj J, Witusik A, Hołub M, Panek M, Górski P, Wujcik R (2010) The sequence polymorphism of MnSOD gene in subjects with respiratory insufficiency in COPD. Med Sci Monit. 16(9): CR427-432.
143. Prasko J, Raszka M, Adamcova K, Grambal A, Koprivova J, Kudrnovská H, Latalova K, Vyskocilová J (2009) Predicting the therapeutic response to cognitive behavioural therapy in patients with pharmacoresistant obsessive-compulsive disorder. Neuroendocrinol Lett. 30(5): 615-23.
144. Ptacek R, Kuzelova H, Paclt I, Zukov I, Fischer S (2009) ADHD and growth: anthropometric changes in medicated and non-medicated ADHD boys. Med Sci Monit. 15(12): CR595-9.
145. Rajender S, Pandu G, Sharma JD, Gandhi KPC, Singh L, Thangaraj K (2008) Reduced CAG repeats length in androgen receptor gene is associated with violent criminal behavior. Int J Legal Med. 122: 367-372.
146. Raszka M, Prasko J, Koprivová J, Novák T, Adamcová K (2009) Psychological dissociation in obsessive-compulsive disorder is associated with anxiety level but not with severity of obsessive-compulsive symptoms. Neuroendocrinol Lett. 30(5): 624-8.
147. Reese J, Kraschewski A, Anghelescu I, Winterer G, Schmidt LG, Gallinat J, Rüschendorf F, Rommelspacher H, Wernicke C (2010) Haplotypes of dopamine and serotonin transporter genes are associated with antisocial personality disorder in alcoholics. Psychiatr Genet. [Epub ahead of print]
148. Salamon E, Esch T, Stefano GB (2005) The role of the amygdala in mediating sexual and emotional behavior via coupled nitric oxide release. Acta Pharmacologica Sinica. 26: 389-395. (Pubitemid 40477985)
149. Salo J, Pulkki-Råback L, Hintsanen M, Lehtimäki T, Keltikangas-Järvinen L (2010) The interaction between serotonin receptor 2A and catechol-O-methyltransferase gene polymorphisms is associated with the novelty-seeking subscale impulsiveness. Psychiatr Genet. [Epub ahead of print].
150. Samuels JF (2009) Recent advances in the genetics of obsessive-compulsive disorder. Curr Psychiatry Rep. 11(4): 277-82.
151. Serretti A, Calati R, Giegling I, Hartmann AM, Möller HJ, Rujescu D (2009) Serotonin receptor HTR1A and HTR2C variants and personality traits in suicide attempters and controls. J Psychiatr Res. 43(5): 519-25.
152. Sharp SI, McQuillin A, Gurling HM (2009) Genetics of attention-deficit hyperactivity disorder (ADHD). Neuropharmacology. 57(7-8): 590-600.
153. Sicard MN, Zai CC, Tiwari AK, Souza RP, Meltzer HY, Lieberman JA, Kennedy JL, Müller DJ (2010) Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysis. Pharmacogenomics. 11(11): 1561-71.
154. Smith TF (2010) Meta-analysis of the heterogeneity in association of DRD4 7-repeat allele and AD/HD: Stronger association with AD/HD combined type. Am J Med Genet B Neuropsychiatr Genet. [Epub ahead of print].
155. Smolarek I, Wyszko E, Barciszewska A, Nowak S, Gawronska I, Jablecka A, Barciszewska M (2010) Global DNA methylation changes in blood of patients with essential hypertension. Med Sci Monit. 16(3): CR149-155.
156. Smoller JW, Sheidley BR, Tsuang MT (2008) Psychiatric Genetics: Applications in Clinical Practice, American Psychiatric Publishing, 337.
157. Sokolowska M, Stefanska J, Wodz-Naskiewicz K, Pawliczak R. Cytosolic phospholipase A2 group IVA influence on GM-CSF expression in human lung cells: A pilot study. Med Sci Monit 2010, 16(9): BR300-306.
158. Sonetti D, Peruzzi E, Stefano GB (2005) Endogenous morphine and ACTH association in neural tissues. Med Sci Monit. 11: MS22-MS30. (Pubitemid 40790946)
159. Squassina A, Lanktree M, De Luca V, Jain U, Krinsky M, Kennedy JL, Muglia P (2008) Investigation of the dopamine D5 receptor gene (DRD5) in adult attention deficit hyperactivity disorder. Neurosci Lett. 432(1): 50-3.
160. Stacey D, Clarke TK, Schumann G (2009) The genetics of alcoholism. Curr Psychiatry Rep. 11(5): 364-9.
161. Stefano G, Esch T, Bilfinger T, Kream R (2010) Proinflammation and preconditioning protection are part of a common nitric oxide mediated process. Med Sci Monit. 16(6): RA125-130
162. Stefano GB, Bianchi E, Guarna M, et al (2007) Nicotine, alcohol and cocaine coupling to reward processes via endogenous morphine signaling: The dopamine-morphine hypothesis. Med Sci Monit. 13: RA91-102.
163. Stefano GB, Burrill JD, Labur S, et al (2005) Regulation of various genes in human leukocytes acutely exposed to morphine: Expression microarray analysis. Med Sci Monit. 11: MS35-MS42. (Pubitemid 40790948)
164. Stefano GB, Cadet P, Kream RM, et al. (2008a). The presence of endogenous morphine signaling in animals. Neurochemical Research. 33: 1933-1939.
165. Stefano GB, Esch T, Kream RM (2009) Xenobiotic perturbation of endogenous morphine signaling: paradoxical opiate hyperalgesia. Med Sci Monit. 15: RA107-RA110.
166. Stefano GB, Fricchione GL, Goumon Y et al (2005) Pain, immunity, opiate and opioid compounds and health. Med Sci Monit. 11: MS47-MS53. (Pubitemid 40790950)
167. Stefano GB, Kream RM, Esch T (2009) Revisiting tolerance from the endogenous morphine perspective. Med Sci Monit. 15: RA189-RA198.
168. Stefano GB, Kream RM, Mantione KJ et al. (2008b). Endogenous morphine/nitric oxide-coupled regulation of cellular physiology and gene expression: implications for cancer biology. Semin Cancer Biol. 18: 199-210.
169. Stefano GB, Kream RM, Mantione KJ, Ptacek R (2011) Endogenous morphine, stress and psychiatric disorders - review of actual findings. Journal of Czech Psychology. In Press.
170. Stefano GB, Kream RM (2007) Endogenous morphine synthetic pathway preceded and gave rise to catecholamine synthesis in evolution (Review). Int J Mol Med. 20: 837-841.
171. Stefano GB, Kream RM (2010) Dopamine, Morphine, and Nitric Oxide: An Evolutionary Signaling Triad. CNS Neurosci Ther. 16: e124-e137.
172. Stefano GB, Scharrer B (1994) Endogenous morphine and related opiates, a new class of chemical messengers. Adv Neuroimmunol, 4: 57-68.
173. Stefano GB, Stefano JM, Esch T (2008) Anticipatory Stress Response: A significant commonality in stress, relaxation, pleasure and love responses. Med Sci Monit. 14: RA17-RA21. (Pubitemid 351263390)
174. Strobel A, Wehr A, Michel A, Brocke B (1999) Association between the dopamine D4 receptor (DRD4) exon III polymorphism and measures of novelty seeking in a German population. Mol Psychiatry. 4: 378-84. (Pubitemid 29440579)
175. Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J, Liu XQ, Vincent JB, Skaug JL, Thompson AP, Senman L et al (2007) Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet. 39: 319-328.
176. Talkowski ME, Kirov G, Bamne M, Georgieva L, Torres G, Mansour H, Chowdari KV, Milanova V, Wood J, McClain L, Prasad K, Shirts B, Zhang J, O'Donovan MC, Owen MJ, Devlin B, Nimgaonkar VL (2008) A network of dopaminergic gene variations implicated as risk factors for schizophrenia. Hum Mol Genet. 17(5): 747-58. (Pubitemid 351292263)
177. Talkowski ME, Mansour H, Chowdari KV, Wood J, Butler A, Varma PG, Prasad S, Semwal P, Bhatia T, Deshpande S et al (2006) Novel, Replicated Associations Between Dopamine D3 Receptor Gene Polymorphisms and Schizophrenia in Two Independent Samples. Biol Psychiatry. 60: 570-577. (Pubitemid 44402378)
178. Tobacco and Genetics Consortium (2010) Genome-wide metaanalyses identify multiple loci associated with smoking behavior. Nat Genet. 42(5): 441-7.
179. Tsunoka T, Kishi T, Kitajima T, Okochi T, Okumura T, Yamanouchi Y, Kinoshita Y, Kawashima K, Naitoh H, Inada T, Ujike H, Yamada M, Uchimura N, Sora I, Iyo M, Ozaki N, Iwata N (2010) Association analysis of GRM2 and HTR2A with methamphetamine-induced psychosis and schizophrenia in the Japanese population. Prog Neuropsychopharmacol Biol Psychiatry. 34(4): 639-44.
180. Unschuld PG, Ising M, Erhardt A, Lucae S, Kloiber S, Kohli M, Salyakina D, Welt T, Kern N, Lieb R, Uhr M, Binder EB, Muller-Myhsok B, Holsboer F, Keck ME (2007) Polymorphisms in the Serotonin Receptor Gene HTR2A Are Associated With Quantitative Traits in Panic Disorder American. Journal of Medical Genetics Part B (Neuropsychiatric Genetics). 144B: 424-429. (Pubitemid 46983148)
181. Vaiman M, Olevson Y, Habler L, Kessler A, Zehavi S, Sandbank J (2010) Diagnostic value of estrogen receptors in thyroid lesions Med Sci Monit. 16(7): BR203-207.
182. van Oorschot OB (2005) 5-HT1B receptors and aggression: a review. Eur J Pharmacol 526: 207-217.
183. Vevera J, Stopkova R, Bes M, Albrecht T, Papezova H, Zukov I, Raboch J, Stopka P (2009) COMT polymorphisms in impulsively violent offenders with antisocial personality disorder. Neuroendocrinol Lett. 30(6): 753-6.
184. Videtic A, Peternelj TT, Zupanc T, Balazic J, Komel R (2009) Promoter and functional polymorphisms of HTR2C and suicide victims. Genes Brain Behav. 8(5): 541-5.
185. Vithoulkas G, Carlino S (2010) The "continuum" of a unified theory of diseases. Med Sci Monit. 16(2): SR7-15.
186. Vlkova B, Szemes T, Minarik G, Turna J, Celec P (2010) Advances in the research of fetal DNA in maternal plasma for noninvasive prenatal diagnostics. Med Sci Monit. 16(4): RA85-91.
187. Watanabe Y, Nunokawa A, Kaneko N, Someya T (2007) The tryptophan hydroxylase 1 (TPH1) gene and risk of schizophrenia: a moderate-scale case-control study and meta-analysis. Neurosci Res. 59(3): 322-6. (Pubitemid 47503381)
188. Yasseen B, Kennedy JL, Zawertailo LA, Busto UE (2010) Comorbidity between bipolar disorder and alcohol use disorder: Association of dopamine and serotonin gene polymorphisms. Psychiatry Res. 176(1): 30-33.
189. Yilmaz Z, Kaplan AS, Zai CC, Levitan RD, Kennedy JL (2011) COMT Val158Met variant and functional haplotypes associated with childhood ADHD history in women with bulimia nervosa. Prog Neuropsychopharmacol Biol Psychiatry. [Epub ahead of print]
190. Zahari Z, Teh LK, Ismail R, Razali SM (2011) Influence of DRD2 polymorphisms on the clinical outcomes of patients with schizophrenia. Psychiatr Genet. [Epub ahead of print]
191. Zai CC, Manchia M, De Luca V, Tiwari AK, Squassina A, Zai GC, Strauss J, Shaikh SA, Freeman N, Meltzer HY, Lieberman J, Le Foll B, Kennedy JL (2010) Association study of BDNF and DRD3 genes in schizophrenia diagnosis using matched case-control and family based study designs. Prog Neuropsychopharmacol Biol Psychiatry. 34(8): 1412-8.
192. Zhang JP, Lencz T, Malhotra AK (2010) D2 Receptor Genetic Variation and Clinical Response to Antipsychotic Drug Treatment: A Meta-Analysis. Am J Psychiatry. [Epub ahead of print]
193. Zhu W, Cadet P, Baggerman G et al. (2005a). Human white blood cells synthesize morphine: CYP2D6 modulation. J Immunol. 175: 7357-7362. (Pubitemid 41713432)
194. Zhu W, Esch T, Kream RM, et al (2008) Converging cellular processes for substances of abuse: endogenous morphine. Neuroendocrinol Lett. 29: 63-66.
195. Zhu W, Mantione K, Kream RM et al (2006) Alcohol-, Nicotine-, and Cocaine-Evoked Release of Morphine from Human White Blood Cells: Substances of Abuse Actions Converge on Endogenous Morphine Release. Med Sci Monit. 12: BR350-BR354. (Pubitemid 44736921)
196. Zhu W, Mantione KJ, Shen L, et al. (2005b). Tyrosine and tyramine increase endogenous ganglionic morphine and dopamine levels in vitro and in vivo: CYP2D6 and tyrosine hydroxylase modulation demonstrates a dopamine coupling. Med Sci Monit. 11: BR397-BR404. (Pubitemid 41695480)